D. Pratt

Time to treatment and survival in triple negative breast cancer patients receiving trimodality treatment in the United States.

M. Karafa, S. Grobmyer, Kelsey E. Larson, 2018, Cancer treatment and research communications.

Stage IV Non-breast Cancer Patients and Screening Mammography: It is Time to Stop

C. Tu, S. Valente, C. K. Gentle, 2022, Annals of Surgical Oncology.

ASO Author Reflections: It is Time to Deescalate Screening Mammography for Patients Who Do Not Benefit

C. K. Gentle, D. Pratt, 2022, Annals of Surgical Oncology.

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

E. Petricoin, P. Nuciforo, J. Wulfkuhle, 2022 .

The effect of wound complications following mastectomy with immediate reconstruction on breast cancer recurrence.

C. Tu, S. Valente, Yitian Liu, 2019, American journal of surgery.

Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction

S. Grobmyer, J. Lang, C. Cakmakoglu, 2022, Breast Cancer Research and Treatment.

Time to Completion of Breast Cancer Treatment and Survival

S. Grobmyer, C. Tu, Talia Burneikis, 2021, Annals of Surgical Oncology.

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

E. Petricoin, P. Nuciforo, J. Wulfkuhle, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

A New Approach to the Treatment of Penetrating Injuries to the Vertebral Artery

M. Modic, David Huang, T. Masaryk, 1998 .

Surgical de-escalation: Are we ready for ‘observation’ of benign high-risk breast lesions found on core needle biopsy?

B. Calhoun, H. Pederson, D. Pratt, 2023, Cleveland Clinic Journal of Medicine.

ASO Author Reflections: Time to Treatment: A New Quality Metric in Breast Cancer Care?

S. Grobmyer, D. Pratt, 2021, Annals of Surgical Oncology.